Serum Cotinine, Serum F2-isoprostane and Risk of Metabolic Syndrome in Adult Male Tobacco Users

##plugins.themes.bootstrap3.article.main##

  •   Haymar Soe Win

  •   Win Yu Aung

  •   Ohn Mar

Abstract

Data on risk of metabolic syndrome among various forms of tobacco consumption in Myanmar tobacco users are currently limited. The present study aimed to determine and compare nicotine metabolites serum cotinine, oxidative stress marker serum F2-isoprostane in adult male tobacco users, and to find out relationships between these parameters and risk of metabolic syndrome. This cross-sectional study was done in 30 to 45 years old males: 84 cigarette smokers, 84 cheroot smokers and 84 betel quid with tobacco chewers. Metabolic syndrome was defined by National Cholesterol Education Program Adult Treatment Panel III definition. Serum cotinine concentration of cigarette smokers was significantly higher than that of cheroot smokers (p=0.026), however, no significant difference was seen between cigarette smokers and betel quid with tobacco chewers (p=1.000), and between cheroot smokers and betel quid with tobacco chewers (p=0.248). Serum F2-isoprostane concentration was significantly higher (p=0.001) in cigarette smokers than cheroot smokers and betel quid with tobacco chewers, but no significant difference was observed between cheroot smokers and betel quid with tobacco chewers (p=1.000). Compared with betel quid with tobacco chewers, cigarette smokers had 5.2 times (95% CI, 2.3-11.4) (p<0.001) and cheroot smokers had 1.4 times (95% CI, 0.62-3.3) (p=0.402) higher risk of having metabolic syndrome. There was a significant association between the presence of metabolic syndrome and high serum cotinine as well as high serum F2-isoprostane. A significant correlation between serum cotinine and serum F2-isoprostane was found in betel quid with tobacco chewers, but not in cigarette smokers and cheroot smokers. The present study showed that both nicotine and oxidative stress take part in the pathogenesis of metabolic syndrome. Cigarette smoking has the highest risk of having metabolic syndrome, however, cheroot smoking as well as betel quid with tobacco chewing is related to metabolic syndrome as well.


Keywords: Cotinine, F2-isoprostane, Metabolic syndrome, Tobacco

References

Gupta PC, Warnakulasuriya S. Global Epidemiology of Areca nut usage. Addiction Biology. 2002; 7: 77-83.

World Health Organization. Myanmar Tobacco factsheet 2018. https://apps.who.int/iris/bitstream/handle/10665/272686/, accessed April 8, 2019.

World Health Organization. WHO report on the global adult tobacco survey 2018. https://www.who.tobacco/publications/surveillance, accessed April 3, 2019.

Jarvis MJ, Primatesta P, Erens B, Feyerabend C, Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine & Tobacco Research. 2003; 5: 349-355.

Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews. 1996; 18: 188-204.

Honarmand M, Nakhaee A, Moradi M. Comparison of salivary cotinine concentrations in male smokers and smokeless tobacco users. Asian Pacific Journal of Cancer Prevention. 2018; 19 (5): 1363-1366.

Singh PN, Natto Z, Saxena R, Bannerjee H, Yel D, Khieng S, et al. Cotinine levels among betel quid users and cigarette smokers in Cambodia. Asia Pacific Journal of Public Health. 2013; 25(5): 84-91.

Calo WA, Ortiz AP, Suárez E, Guzmán M, Pérez CM. Association of cigarette smoking and metabolic syndrome in a Puerto Rican adult population. Journal of Immigrant and Minority Health. 2013; 15(4): 810-816.

Phyo Ohnmar Swe. Relationship between betel quid chewing and metabolic risk markers. [MMedSc thesis]. Department of Physiology, University of Medicine 1: Yangon; 2018.

Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: the oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases. 2010; 20: 72-77.

Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers—Smoking as a cause of oxidative damage. New England Journal of Medicine. 1995; 332: 1198-1203.

Sinzinger H, Kaliman J, Oguogho A. Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokers. Lymphology. 2000; 33: 24-31.

Ande, A. Cytochrome P450 enzymes and oxidative stress in tobacco/nicotine mediated HIV pathogenesis. [Ph. D Dissertation]. Andhra University: Missouri; 2016.

McGrath TE, Chan WG, Hajaligol MR. Low temperature mechanism for the formation of polycyclic aromatic hydrocarbons from the pyrolysis of cellulose. Journal of Analytical and Applied Pyrolysis. 2003; 66: 51-70.

Leffingwell JC. Chemical constituents of tobacco leaf and differences among tobacco type. http://preprint.chemweb.com/orgchem/0102001, accessed Oct 3, 2016.

Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environmental Health Perspectives. 1985; 64: 111-126.

Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in Vivo: An Overview. Biomarkers. 2005; 10(1): S10-S23.

van't Erve TJ, Kadiiskaa MB, London SJ, Masona RP. Classifying oxidative stress by F2-isoprostane levels across human diseases. Redox Biology. 2017; 12: 582-599.

Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan, B, et al. Factors associated with oxidative stress in human populations. American Journal of Epidemiology. 2002; 156: 274-285.

Black CN, Bot M, Scheffer PG, Penninx BWJH. Sociodemographic and lifestyle determinants of plasma oxidative stress markers 8-OHdG and F2-isoprostanes and associations with metabolic syndrome. Oxidative Medicine and Cellular Longevity. 2016. https://www.hindawi.com/journals/omcl/2016/7530820/, accessed April 23, 2017.

National Cholesterol Education Program: Adult Treatment Panel III (NCEP/ATP III). Third report of the National Cholesterol Education Program: Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation. 2001; 106: 3143–3421.

SRNT Subcommittee of the Society for Research on Nicotine and Tobacco. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research. 2002; 4: 149-159.

Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. American Journal of Epidemiology. 2009; 169: 236-248.

Smith JJ, Robinson RF, Khan BA, Sosnoff CS, Dillard DA. Estimating cotinine associations and a saliva cotinine level to identify active cigarette smoking in Alaska native pregnant women. Maternal and Child Health Journal. 2014; 18: 120-128.

Thein KN, Win M, Hlaing TT, Tin N. A study of the effects of tobacco smoking on lipid profile of apparently healthy Myanmar adults. A paper presented at 38th Myanmar Health Research Congress; 2010, Jan; Department of Medical Research (Lower Myanmar), Yangon, Myanmar.

Ayo-Yusuf OA, Swart TJP, Pickworth WB. Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tobacco Control. 2004; 13: 186-189.

Behera D, Uppal R, Majumdar S. Urinary levels of nicotine & cotinine in tobacco users. Indian Journal of Medical Research. 2003; 118: 129-133.

Masahiko M. Cheroots in Myanmar, beyond rural development. (2019).

Nair UJ, Obe G, Friesen M, Goldberg MT, Bartsch H. Role of lime in the generation of reactive oxygen species from betel-quid ingredients. Environmental Health Perspectives. 1992; 98: 203-205.

Pasquali R, Vicennati V. Activity of the hypothalamicpituitary-adrenal axis in different obesity phenotypes. International Journal of Obesity Related Metabolic Disorders. 2000; 24: S47-S49.

Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. International Journal of Obesity. 2001; 25: 1225-1232.

Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamus-pituitary-adrenal axis through a centrally mediated corticotrophin releasing hormone dependent mechanism. Endocrinology. 1989; 125(5): 2445-2453.

Baradaran A, Nasri H, Kopael MR. Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. Journal of Research in Medical Sciences. 2014; 19(4): 358-367.

Zhu YX, Zhang ML, Hou XH, Lu JX, Peng LP, Gu HL, et al. Cigarette smoking increases risk for incident metabolic syndrome in chinese men—Shanghai diabetes study. Biomedical and Environmental Sciences. 2011; 24: 475‐482.

Holme I, Tonstad S, Sogaard AG, Larsen L, Haheim LL. Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study. BMC Public Health. 2007; 7(154): 1-7.

Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Industrial Health. 2005; 43: 295-301.

Guh JY, Chaung LY, Chen HC. Betel-quid use is associated with the risk of the metabolic syndrome in adults. American Journal of Clinical Nutrition. 2006; 83: 1313-1320.

Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circulation Journal. 2006; 70: 1437-1442.

Kim BJ, Han JM, Kang JG, Rhee EJ, Kim BS, Kang JH. Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults. Journal of Clinical Lipidology. 2017; 11(3): 638-645.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Win, H. S., Aung, W. Y., & Mar, O. (2021). Serum Cotinine, Serum F2-isoprostane and Risk of Metabolic Syndrome in Adult Male Tobacco Users. European Journal of Medical and Health Sciences, 3(1), 62-67. https://doi.org/10.24018/ejmed.2021.3.1.604